BACKGROUND Fibromyalgia syndrome (FMS) is characterized by widespread pain and lowered pain threshold. FMS affects an estimated 2% of the population, but optimal management of FM is still unknown. OBJECTIVE To compare the treatment effect between Tuina therapy plus Baduanjin exercise with Tuina therapy only for the management of patient with fibromyalgia syndrome. METHODS Patients with fibromyalgia syndrome were randomly divided into 2 groups. Patients in the experimental group received the Tuina therapy and Baduanjin exercise. Patients in the control group received Tuina therapy only. The VAS, pain threshold and FIQ scores were assessed. RESULT AND CONCLUSION Tuina therapy is efficacious in relieving pain in patients with FMS. In addition, when combined with baduanjin exercise we can resolve the other core symptoms of the syndrome including fatigue and sleep disturbance. Furthermore the treatment program was effective in improving quality of life for patients with FMS.
基金：
the Guangdong
finance department special foundation: Research on the
inheritance and application of Lingnan Lin’s Chinese
manipulation Tuina (No. 2013kt1531).
基金编号：No. 2013kt1531
语种：
外文
WOS：
第一作者：
第一作者机构：[1]The 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, 510120
通讯作者：
推荐引用方式(GB/T 7714)：
Tian Qiang,Guo Ru-song,Lam Chung Kiu,et al.Effect of Tuina Therapy and Baduanjin Exercise for Primary Fibromyalgia Syndrome A prospective, randomized study[J].2013 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM).2013,doi:10.1109/BIBM.2013.6732685.
APA：
Tian Qiang,Guo Ru-song,Lam, Chung Kiu&Wu Shan.(2013).Effect of Tuina Therapy and Baduanjin Exercise for Primary Fibromyalgia Syndrome A prospective, randomized study.2013 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM),,
MLA：
Tian Qiang,et al."Effect of Tuina Therapy and Baduanjin Exercise for Primary Fibromyalgia Syndrome A prospective, randomized study".2013 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM) .(2013)
